Dominique Januel Selected Research

Therapeutics

1/2024	Clozapine-induced cholinergic urticaria: a case report.
9/2016	[Cognitive remediation and nursing care].
1/2016	Neural correlates of cognitive improvements following cognitive remediation in schizophrenia: a systematic review of randomized trials.
9/2004	Repetitive transcranial magnetic stimulation as an add-on therapy in the treatment of mania: a case series of eight patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominique Januel Research Topics

Disease

7	Schizophrenia (Dementia Praecox) 01/2024 - 12/2002
6	Treatment-Resistant Depressive Disorder 05/2023 - 08/2002
4	Bipolar Disorder (Manic Depressive Psychosis) 12/2023 - 09/2003
4	Hallucinations (Hallucination) 04/2019 - 05/2010
3	Mental Disorders (Mental Disorder) 12/2023 - 01/2006
2	Catatonia 01/2023 - 10/2002
2	Depressive Disorder (Melancholia) 11/2014 - 01/2006
1	Treatment-Resistant Schizophrenia 01/2024
1	Seizures (Absence Seizure) 01/2024
1	Myocarditis (Carditis) 01/2024
1	Urticaria (Hives) 01/2024
1	Pain (Aches) 12/2023
1	Priapism 01/2022
1	Mood Disorders (Mood Disorder) 06/2019
1	Major Depressive Disorder (Major Depressive Disorders) 06/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019
1	Tobacco Use Disorder (Nicotine Dependence) 01/2018
1	Benign essential blepharospasm 01/2017
1	Stroke (Strokes) 01/2017
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2016
1	Mania (Manias) 09/2004

Drug/Important Bio-Agent (IBA)

5	salicylhydroxamic acid (SHAM)IBA 04/2019 - 09/2004
3	Antidepressive Agents (Antidepressants)IBA 06/2019 - 08/2002
2	LithiumIBA 12/2023 - 08/2002
2	mesoglycanIBA 01/2023 - 01/2019
2	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 12/2002
1	Histamine Antagonists (Antihistamines)IBA 01/2024
1	Clozapine (Clozaril)FDA LinkGeneric 01/2024
1	Cholinergic Agents (Cholinergics)IBA 01/2024
1	Analgesics (Analgesic Drugs)IBA 12/2023
1	SaltsIBA 12/2023
1	CytokinesIBA 02/2023
1	BenzodiazepinesIBA 01/2023
1	Olanzapine (Zyprexa)FDA Link 01/2022
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2022
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 04/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 11/2014
1	Therapeutic UsesIBA 05/2010
1	Clomipramine (Anafranil)FDA LinkGeneric 09/2003

Therapy/Procedure

13	Transcranial Magnetic Stimulation 05/2023 - 10/2002
4	Therapeutics 01/2024 - 09/2004
4	Transcranial Direct Current Stimulation 01/2023 - 01/2017
1	Drug Tapering 01/2024
1	Cognitive Training 01/2016